{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:01:10Z","timestamp":1760241670373,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>The aim of this paper was to explore pharmacists\u2019 views on reclassifications from pharmacy-only to general sales and their experiences with the supply of these medicines, in addition to pharmacists\u2019 views on the reclassification of the shingles vaccine and sildenafil to be available through \u2018accredited\u2019 pharmacists. New Zealand community pharmacists were surveyed in 2013 with a written questionnaire of six Likert-style or open-ended questions sent to Pharmacy Guild member pharmacies. The analysis involved descriptive statistics. Responses were received from 246 pharmacies. Two thirds of pharmacists supported the reclassification of the shingles vaccine and sildenafil, although 14% disagreed with the sildenafil reclassification. Over 90% of pharmacists disagreed with the reclassification of paracetamol and ibuprofen liquids, omeprazole, naproxen, and oxymetazoline from pharmacy-only medicine to general sales. This opinion was strongest for omeprazole. With liquid paracetamol and ibuprofen, pharmacists described consumer confusion with dosing, and particularly potentially doubling-up on liquid analgesics\/antipyretics including using both prescription and non-prescription variants. Many reported giving safety advice frequently. Anti-inflammatories and omeprazole were also subject to potential double-dosing, as well as requests by consumers with contraindications, precautions, and drug interactions, and for inappropriate indications. Pharmacists described various interventions, including some that were potentially life-saving. Pharmacy availability of medicines provides the potential for intervention that would not happen in a general sales environment.<\/jats:p>","DOI":"10.3390\/pharmacy6030059","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T10:56:52Z","timestamp":1530529012000},"page":"59","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists\u2019 Views and Experiences"],"prefix":"10.3390","volume":"6","author":[{"given":"Natalie","family":"Gauld","sequence":"first","affiliation":[{"name":"Natalie Gauld Ltd., P. O. Box 9349, Newmarket, Auckland 1149, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Independent Researcher, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3821\/145.2.cpj73","article-title":"Results of a national survey on otc medicines, part 2: Do pharmacists support switching prescription agents to over-the-counter status?","volume":"145","author":"Lalonde","year":"2012","journal-title":"Can. Pharm. J."},{"key":"ref_2","first-page":"150","article-title":"Pharmacists and deregulation: The case of h2-antagonists","volume":"13","author":"Erwin","year":"1996","journal-title":"J. Soc. Adm. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/J058v04n04_02","article-title":"Attitudes of pharmacists toward rx-to-otc switches and their effect on pharmacists\u2019 overall judgment of switch appropriateness","volume":"4","author":"Madhavan","year":"1990","journal-title":"J. Pharm. Mark. Manag."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.sapharm.2013.04.007","article-title":"Pharmacists\u2019 adoption into practice of newly reclassified medicines from diverse therapeutic areas in scotland: A quantitative study of factors associated with decision-making","volume":"10","author":"Paudyal","year":"2014","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1345\/aph.1C134","article-title":"Economic impact of pharmacists\u2019 interventions with nonsteroidal antiinflammatory drugs","volume":"41","author":"Guignard","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pds.2241","article-title":"Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in germany","volume":"21","author":"Eickhoff","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.2042-7174.2010.00091.x","article-title":"Non-prescription medicines and australian community pharmacy interventions: Rates and clinical significance","volume":"19","author":"Williams","year":"2011","journal-title":"Int. J. Pharm. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1367493513496663","article-title":"Management of children\u2019s fever by parents and caregivers: Practical measurement of functional health literacy","volume":"18","author":"Emmerton","year":"2013","journal-title":"J. Child Health Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1509\/jppm.14.061","article-title":"Dangerous double dosing: How naive beliefs can contribute to unintentional overdose with over-the-counter drugs","volume":"34","author":"Catlin","year":"2015","journal-title":"J. Public Policy Mark."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1099-1557(200005\/06)9:3<207::AID-PDS483>3.0.CO;2-S","article-title":"Surveillance of a recently switched non-prescription medicine (diclofenac) using a pharmacy-based approach","volume":"9","author":"Gauld","year":"2000","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1365-2133.2005.06513.x","article-title":"Use of nonprescription topical steroids: Patients\u2019 experiences","volume":"152","author":"Rogers","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gauld, N.J., Kelly, F.S., Emmerton, L.M., and Buetow, S.A. (2015). Widening consumer access to medicines: A comparison of prescription to non-prescription medicine switch in Australia and New Zealand. PLoS ONE.","DOI":"10.1371\/journal.pone.0119011"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gauld, N.J., Kelly, F.S., Kurosawa, N., Bryant, L.J.M., Emmerton, L.M., and Buetow, S.A. (2014). Widening consumer access to medicines through switching medicines to non-prescription: A six country comparison. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107726"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11096-007-9084-4","article-title":"Community pharmacists\u2019 views, attitudes and early experiences of over-the-counter simvastatin","volume":"29","author":"Hansford","year":"2007","journal-title":"Pharm. World Sci."},{"key":"ref_15","first-page":"209","article-title":"An examination of the risk management issues in the handling at home of over-the-counter medicines purchased for children","volume":"271","author":"Conroy","year":"2003","journal-title":"Pharm. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.clinthera.2006.05.010","article-title":"Determinants of antipyretic misuse in children up to 5 years of age: A cross-sectional study","volume":"28","author":"Bilenko","year":"2006","journal-title":"Clin. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11096-012-9668-5","article-title":"Pharmacists\u2019 Perceived integration into practice of over-the-counter simvastatin five years post reclassification","volume":"34","author":"Paudyal","year":"2012","journal-title":"Int. J. Clin Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jac\/dkq409","article-title":"Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand","volume":"66","author":"Gauld","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11096-016-0388-0","article-title":"Pharmacist-only trimethoprim: Pharmacist satisfaction on their training and the impact on their practice","volume":"38","author":"Braund","year":"2016","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_20","unstructured":"(2018, April 29). Paracetamol Fact Sheet. Available online: http:\/\/www.poisons.co.nz\/factp.php?f=33."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.healthpol.2012.12.006","article-title":"Non-prescription medicines for pain and fever-a comparison of recommendations and counseling from staff in pharmacy and general sales stores","volume":"110","author":"Bardage","year":"2013","journal-title":"Health Policy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00007611-200295050-00014","article-title":"Awareness and use of over-the-counter pain medications: A survey of emergency department patients","volume":"95","author":"Cham","year":"2002","journal-title":"South Med. J."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/6\/3\/59\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:10:56Z","timestamp":1760195456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/6\/3\/59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["pharmacy6030059"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy6030059","relation":{},"ISSN":["2226-4787"],"issn-type":[{"type":"electronic","value":"2226-4787"}],"subject":[],"published":{"date-parts":[[2018,7,2]]}}}